174 related articles for article (PubMed ID: 3843296)
1. NK cells and tumor immunity: 1984.
Herberman RB
Year Immunol; 1985; ():93-9. PubMed ID: 3843296
[No Abstract] [Full Text] [Related]
2. Selective inhibition of human and mouse natural killer tumor recognition using retroviral antisense in primary natural killer cells: involvement with MHC class I killer cell inhibitory receptors.
Ortaldo JR; Mason AT; Mason LH; Winkler-Pickett RT; Gosselin P; Anderson SK
J Immunol; 1997 Feb; 158(3):1262-7. PubMed ID: 9013968
[TBL] [Abstract][Full Text] [Related]
3. Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth.
Herberman RB
Concepts Immunopathol; 1985; 1():96-132. PubMed ID: 3916408
[No Abstract] [Full Text] [Related]
4. Effector immune mechanisms in cancer.
Lotzová E
Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
[No Abstract] [Full Text] [Related]
5. [NK cells and NKT cells].
Satoh T; Arase H
Nihon Rinsho; 2005 Apr; 63 Suppl 4():159-65. PubMed ID: 15861651
[No Abstract] [Full Text] [Related]
6. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
7. Vital involvement of a natural killer cell activation receptor in resistance to viral infection.
Brown MG; Dokun AO; Heusel JW; Smith HR; Beckman DL; Blattenberger EA; Dubbelde CE; Stone LR; Scalzo AA; Yokoyama WM
Science; 2001 May; 292(5518):934-7. PubMed ID: 11340207
[TBL] [Abstract][Full Text] [Related]
8. Role of natural killer cells in the mechanism of the antitumor effect of interferon on Moloney sarcoma virus-transformed cells.
Fresa KL; Murasko DM
Cancer Res; 1986 Jan; 46(1):81-8. PubMed ID: 3940213
[TBL] [Abstract][Full Text] [Related]
9. [NK cells--their role and importance in antitumor resistance].
Mircheva Zh
Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
[No Abstract] [Full Text] [Related]
10. Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia.
Romanski A; Bug G; Becker S; Kampfmann M; Seifried E; Hoelzer D; Ottmann OG; Tonn T
Exp Hematol; 2005 Mar; 33(3):344-52. PubMed ID: 15730858
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.
Fletcher JM; Prentice HG; Grundy JE
J Immunol; 1998 Sep; 161(5):2365-74. PubMed ID: 9725232
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cells.
Kimber I
Med Lab Sci; 1985 Jan; 42(1):60-77. PubMed ID: 2580211
[No Abstract] [Full Text] [Related]
13. [Cytotoxic activity of the effector cells as a factor in protective immunity in helminthiases (a review of the literature)].
Leĭkina ES
Med Parazitol (Mosk); 1983; 52(2):58-65. PubMed ID: 6343821
[No Abstract] [Full Text] [Related]
14. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
15. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
[TBL] [Abstract][Full Text] [Related]
16. Immunology. Stress, NK receptors, and immune surveillance.
Pardoll DM
Science; 2001 Oct; 294(5542):534-6. PubMed ID: 11567108
[No Abstract] [Full Text] [Related]
17. Augmentation of NK cell activity by IL-2.
Herberman RB
Prog Clin Biol Res; 1987; 244():267-74. PubMed ID: 3498952
[No Abstract] [Full Text] [Related]
18. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells in relation to disease and treatment.
Pedersen BK
Allergy; 1985 Nov; 40(8):547-57. PubMed ID: 3911816
[No Abstract] [Full Text] [Related]
20. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
